202 related articles for article (PubMed ID: 31917969)
1. Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs.
Seaman MS; Bilska M; Ghantous F; Eaton A; LaBranche CC; Greene K; Gao H; Weiner JA; Ackerman ME; Garber DA; Rosenberg YJ; Sarzotti-Kelsoe M; Montefiori DC
J Immunol Methods; 2020 Apr; 479():112736. PubMed ID: 31917969
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies.
Bharadwaj P; Riekofski C; Lin S; Seaman MS; Garber DA; Montefiori D; Sarzotti-Kelsoe M; Ackerman ME; Weiner JA
J Immunol Methods; 2020 Apr; 479():112764. PubMed ID: 32070674
[TBL] [Abstract][Full Text] [Related]
3. Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.
van Dorsten RT; Reh L; Trkola A; Morris L; Moore PL
J Virol; 2022 Feb; 96(4):e0193421. PubMed ID: 34935437
[TBL] [Abstract][Full Text] [Related]
4. Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target.
Sherpa C; Le Grice SFJ
Curr HIV Res; 2020; 18(2):114-131. PubMed ID: 32039686
[TBL] [Abstract][Full Text] [Related]
5. Broadly Neutralizing Antibodies for HIV-1 Prevention.
Walsh SR; Seaman MS
Front Immunol; 2021; 12():712122. PubMed ID: 34354713
[TBL] [Abstract][Full Text] [Related]
6. The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.
Thavarajah JJ; Hønge BL; Wejse CM
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932203
[TBL] [Abstract][Full Text] [Related]
7. Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
Ding C; Patel D; Ma Y; Mann JFS; Wu J; Gao Y
Front Immunol; 2021; 12():697683. PubMed ID: 34354709
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives.
Mahomed S
Clin Microbiol Rev; 2024 Jun; 37(2):e0015222. PubMed ID: 38687039
[TBL] [Abstract][Full Text] [Related]
9. Broadly Neutralizing Antibodies for HIV Prevention.
Karuna ST; Corey L
Annu Rev Med; 2020 Jan; 71():329-346. PubMed ID: 31986089
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
Rosenberg Y; Sack M; Montefiori D; Labranche C; Lewis M; Urban L; Mao L; Fischer R; Jiang X
PLoS One; 2015; 10(3):e0120451. PubMed ID: 25807114
[TBL] [Abstract][Full Text] [Related]
11. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing antibodies targeting HIV: Progress and challenges.
Paneerselvam N; Khan A; Lawson BR
Clin Immunol; 2023 Dec; 257():109809. PubMed ID: 37852345
[TBL] [Abstract][Full Text] [Related]
14. Broadly Neutralizing Antibodies against HIV: Back to Blood.
Dashti A; DeVico AL; Lewis GK; Sajadi MM
Trends Mol Med; 2019 Mar; 25(3):228-240. PubMed ID: 30792120
[TBL] [Abstract][Full Text] [Related]
15. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
16. Vaccinal effect of HIV-1 antibody therapy.
Naranjo-Gomez M; Pelegrin M
Curr Opin HIV AIDS; 2019 Jul; 14(4):325-333. PubMed ID: 30973419
[TBL] [Abstract][Full Text] [Related]
17. Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?
Hsu DC; Mellors JW; Vasan S
Front Immunol; 2021; 12():710044. PubMed ID: 34322136
[TBL] [Abstract][Full Text] [Related]
18. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
Zhang Y; Chapman JH; Ulcay A; Sutton RE
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
[TBL] [Abstract][Full Text] [Related]
19. Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121.
Lee WS; Reynaldi A; Amarasena T; Davenport MP; Parsons MS; Kent SJ
Front Immunol; 2021; 12():749891. PubMed ID: 34867979
[TBL] [Abstract][Full Text] [Related]
20. Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
Hraber P; Rademeyer C; Williamson C; Seaman MS; Gottardo R; Tang H; Greene K; Gao H; LaBranche C; Mascola JR; Morris L; Montefiori DC; Korber B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]